Increased proliferation of human synovial mesenchymal stem cells with autologous human serum: Comparisons with bone marrow mesenchymal stem cells and with fetal bovine serum
Open Access
- 31 January 2008
- journal article
- research article
- Published by Wiley in Arthritis & Rheumatism
- Vol. 58 (2), 501-510
- https://doi.org/10.1002/art.23219
Abstract
Objective Synovial mesenchymal stem cells (MSCs) are a promising cell source for cartilage regeneration due to their high chondrogenic potential. For clinical safety, autologous human serum should be used instead of fetal bovine serum (FBS). We undertook this study to compare the 2 types of serum for their enhancement of the proliferation and chondrogenic potentials of synovial MSCs and to investigate the mechanisms of the differences. Since effectiveness of the sera might depend on the origin of the MSCs, we also examined bone marrow MSCs. Methods Synovium, bone marrow, and peripheral blood were obtained from 18 donors. Synovial and bone marrow MSCs were cultured with autologous human serum or FBS and analyzed. In addition, rabbit synovial MSCs cultured with autologous serum or FBS were transplanted into full‐thickness cartilage defects of the knees of the same rabbits. Results Human synovial MSCs expanded more in human serum than in FBS, and the opposite results were obtained with bone marrow MSCs. Hierarchical clustering analysis showed that the cell source, rather than the type of serum, affected the gene expression profile. Human serum contained high levels of platelet‐derived growth factor (PDGF), synovial MSCs expressed higher levels of PDGF receptor α than did bone marrow MSCs, and neutralizing PDGF decreased the proliferation of synovial MSCs with autologous human serum. Although the in vitro chondrogenic potential of human synovial MSCs was affected by the serum source, the in vivo chondrogenic potential of rabbit synovial MSCs was similar in autologous serum and FBS groups. Conclusion Autologous serum predominates in increasing the proliferation of synovial MSCs with chondrogenic potential through PDGF signaling.Keywords
This publication has 32 references indexed in Scilit:
- Synovial Stem Cells Are Regionally Specified According to Local Microenvironments After Implantation for Cartilage RegenerationThe International Journal of Cell Cloning, 2006
- Motility and growth of human bone-marrow mesenchymal stem cells during ex vivo expansion in autologous serumThe Journal of Bone and Joint Surgery. British volume, 2005
- In vitro chondrogenesis of human synovium-derived mesenchymal stem cells: Optimal condition and comparison with bone marrow-derived cellsJournal of Cellular Biochemistry, 2005
- Autologous serum for isolation and expansion of human mesenchymal stem cells for clinical useExperimental Hematology, 2004
- Isolation and characterization of bone marrow multipotential mesenchymal progenitor cellsArthritis & Rheumatism, 2002
- Bone marrow stromal cells prepared using AB serum and bFGF for hematopoietic stem cells expansionTransfusion, 2002
- Alternatives to Animal Sera for Human Bone Marrow Cell Expansion: Human Serum and Serum-Free MediaJournal of Hematotherapy, 1998
- A new variant of Creutzfeldt-Jakob disease in the UKThe Lancet, 1996
- Mesenchymal stem cellsJournal of Orthopaedic Research, 1991
- Ligand-induced interaction between .alpha.- and .beta.-type platelet-derived growth factor (PDGF) receptors: role of receptor heterodimers in kinase activationBiochemistry, 1991